Log on / register
Feedback | Support | My details

Pre-publication history

Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer

Demosthenes Makris email, Arnaud Scherpereel email, Marie Christine Copin email, Guillaume Colin email, Luc Brun email, Jean Jacques Lafitte email and Charles Hugo Marquette email

BMC Cancer 2007, 7:150doi:10.1186/1471-2407-7-150

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript30 Sep 2006
Reviewer's ReportChristopher Azzoli30 Jan 2007
Resubmission - Version 2ManuscriptAuthors' comments24 Apr 2007
Reviewer's ReportChristopher Azzoli28 May 2007
Resubmission - Version 3ManuscriptAuthors' comments24 Jun 2007
Resubmission - Version 4ManuscriptAuthors' comments01 Aug 2007
Resubmission - Version 5Manuscript03 Aug 2007
Accepted05 Aug 2007
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.